ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that the Company’s third quarte…
Author: Business Wire
ModMed introduces single-screen SOAP notes
BOCA RATON, Fla.–(BUSINESS WIRE)–ModMed® announced a single-screen SOAP note into the leading EHR for eye care, EMA®, enabling ophthalmologists to streamline their workflow.
FDA Grants Breakthrough Device Status to Toku’s Patented Cardiovascular Risk AI (CLAiR) Platform
AUCKLAND, New Zealand–(BUSINESS WIRE)–Toku, Inc., a commercial medical device company specializing in imaging technology and AI, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to its patented CL…
Baxter Reports Third-Quarter 2023 Results
DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2023. “Baxter continues to successfully execute upon the slate of strategic actions we announced at the out…
Verana Health Partners with Foundation Fighting Blindness to Integrate Genetic Testing Data into Real-World Evidence Research
SAN FRANCISCO & COLUMBIA, Md.–(BUSINESS WIRE)–Verana Health® (Verana), a digital health company helping to revolutionize patient care and clinical research by unlocking the potential of real-world data, and the Foundation Fighting Blindness – the wor…
NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and nine months ended September 30, 2023 after market close on Thursday, November 9, 2023 and will ho…
Glaukos Announces Third Quarter 2023 Financial Results
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financ…
STAAR Surgical Reports Third Quarter 2023 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today reported financial results…
6-Year Data Published in Journal of Glaucoma Demonstrates Effective, Sustained Reduction in Intraocular Pressure with iTrack™ Canaloplasty
FREMONT, Calif.–(BUSINESS WIRE)–Nova Eye Medical Limited, a medical technology company committed to advanced ophthalmic treatment technologies and devices, is pleased to announce the peer review publication of 6-year data in Journal of Glaucoma that …
Aldeyra Therapeutics Enters into Exclusive Option Agreement with AbbVie for License to Develop and Commercialize Reproxalap
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that it has entered i…
Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2023 financial results. “We continue to grow rev…
Aura Biosciences to Present Updated Phase 2 Data Evaluating Suprachoroidal Administration of Belzupacap Sarotalocan (Bel-sar) for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at AAO 2023
BOSTON–(BUSINESS WIRE)–Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that updated data from the Ph…
Rising Awareness and Aging Population Propel Global Contact Lenses Market to $9.77 Billion in 2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Contact Lenses Market – Focused Insights 2024-2029” report has been added to ResearchAndMarkets.com’s offering. The global contact lenses market, valued at $9.77 billion in 2023, is projected to grow significantly, …
Humana Repeats as U.S. News & World Report’s Best Overall Medicare Advantage Plan Company for Second Year in a Row
LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana repeats as U.S. News & World Report’s Best Overall Medicare Advantage Plan Company for the second year in a row.
RMK Launches Color Blind Glasses ‘Dalton’
SEJONG, South Korea–(BUSINESS WIRE)–Korean venture company RMK launched Dalton, a sunglass designed for color blindness correction.
National Vision Holdings, Inc. Announces Participation in the Jefferies London Healthcare Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) today announced that members of its management team are scheduled to present at the Jefferies London Healthcare Conference on Tuesday, November 14, 2023, at 6:30 a.m. EST (11:30…
Epion Therapeutics Initiates Phase 3 Clinical Trials for Minimally-Invasive Keratoconus Treatment
BURLINGTON, Mass.–(BUSINESS WIRE)–Epion Therapeutics (Epion) announced the commencement of its Phase 3 Apricity trials for EpiSmart™, the company’s minimally-invasive keratoconus therapy. This marks a milestone in the company’s mission to redefine th…
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual Meeting
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that i…
Toku joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
SAN DIEGO–(BUSINESS WIRE)–Toku Inc, a provider of an AI-based screening tool for detection of cardiovascular risk through retinal imaging, has joined the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovato…
Three Ophthalmic Labs in North America Sign to Acquire flō Platforms
TEL AVIV, Israel–(BUSINESS WIRE)–flō is happy to share that it has signed agreements with three laboratories that will acquire, install, and assist in evaluating the first flō Platforms to be released in 2024. These labs will be the first to have acc…